Showing results (181-190 of 226) with videos related to

Sort By:
Pageof 23
Frontiers in Immunology|January 10, 2022
Integrated Lymphopenia Analysis in Younger and Older Patients With Multiple Sclerosis Treated With Cladribine TabletsGavin Giovannoni, Patricia K Coyle, Patrick Vermersch, et al.
Multiple Sclerosis and Related Disorders|May 30, 2020
Teriflunomide vs injectable disease modifying therapies for relapsing forms of MSPatrick Vermersch, Jiwon Oh, Mark Cascione, et al.
Psychological Reports|December 14, 2004
Normative data for the selective reminding test: a random digit dialing sampleWilliam F Scherl, Lauren B Krupp, Christopher Christodoulou, et al.
Archives of Neurology|November 1, 1991
Cognitive functioning in late Lyme borreliosisL B Krupp, D Masur, J Schwartz, et al.
Neurodegenerative Disease Management|August 26, 2022
Relapses in people with multiple sclerosis treated with cladribine tablets followed for up to 5 years: a plain language summaryNicola De Stefano, Maria Pia Sormani, Gavin Giovannoni, et al.
The Lancet. Neurology|September 16, 2008
Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trialDaniel D Mikol, Frederik Barkhof, Peter Chang, et al.
The Journal of Infectious Diseases|January 1, 2003
Human T lymphocyte response to Borrelia burgdorferi infection: no correlation between human leukocyte function antigen type 1 peptide response and clinical statusRichard S Kalish, Jonathan A Wood, William Golde, et al.
Health Technology Assessment (Winchester, England)|June 3, 2008
A systematic review of the clinical effectiveness and cost-effectiveness and economic modelling of minimal incision total hip replacement approaches in the management of arthritic disease of the hipR de Verteuil, M Imamura, S Zhu, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 21, 2017
The efficacy of cladribine tablets in CIS patients retrospectively assigned the diagnosis of MS using modern criteria: Results from the ORACLE-MS studyMark S Freedman, Thomas P Leist, Giancarlo Comi, et al.
Neurology|November 1, 1995
Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placeboL B Krupp, P K Coyle, C Doscher, et al.
Pageof 23